SHANGHAI and HONG KONG, Jan. 15, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for...
Hence then, the article about antengene presents at jpm strong clinical data update and strategic focus on next generation adcs and tces was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Antengene Presents at JPM: Strong Clinical Data Update and Strategic Focus on Next-Generation ADCs and TCEs )
Also on site :
- UK to list 65-year-olds as reservists amid Russia threat claims – Telegraph
- Scott Ritter say he was ‘de-banked’
- AI boom fuels fears of an industry bubble (VIDEO)